Evaluation of Statin Indication and Dose Intensification Among Type 2 Diabetic Patients at a Tertiary Hospital
Open Access
- 1 March 2024
- journal article
- research article
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 17, 1157-1169
Abstract
Background: Diabetes mellitus (DM) increases cardiovascular disease (CVD) incidence and mortality. While guidelines endorse statin use in type 2 DM (T2DM) to mitigate cardiovascular risks and mortality, challenges like statin initiation and prompt treatment adjustments affect patient outcomes. This study aimed to assess the appropriateness of indications for and dose intensification of statin therapy among T2DM patients at Tikur Anbessa Specialized Hospital (TASH). Methodology: A hospital-based cross-sectional study was conducted from April 1 to June 30 2020. In total, 405 T2DM patients were selected using a systematic random sampling technique. The data were analyzed using SPSS version 26.0. An adjusted odds ratio (OR) was used and a 95% confidence interval (CI) and p-values of < 0.05 were utilized to determine statistical significance. Results: Of the total 405 participants, 346 (85.4%) started taking statins for primary or secondary prevention purposes. Indication for statin use was appropriate in 96.2% patients, while for 216 (62.4%) patients their doses were appropriately intensified. Predictors of the inappropriateness of statin use were an atherosclerotic cardiovascular disease (ASCVD) score of ≥ 7.5% (AOR=0.28; 95% CI: 0.102– 0.738, p=0.01), the presence of dyslipidemia (AOR=4.48; 95% CI: 1.85– 10.84; p=0.001), initiation of aspirin therapy (AOR=3.7; 95% CI: 1.522– 9.144; p=0.004), and an LDL-cholesterol level of 70– 189 mg/dL (AOR=0.124; 95% CI: 0.042– 0.365; p=0.001). DM duration of ≥ 10 years (AOR=2.51; 95% CI: 1.35– 4.66, p=0.004), male gender (AOR=2.04; 95% CI: 1.16– 3.58, p=0.013), age ≥ 65 years (AOR=2.15; 95% CI: 1.23– 3.75, p=0.007) and uncontrolled blood pressure (AOR=2.09; 95% CI: 1.07– 4.08, p=0.031) were associated with inappropriate statin intensification. Conclusion: The study found that indication of statins was optimal and about two-thirds of patients had their doses appropriately intensified. Monitoring is needed to avoid inappropriate intensification of statin therapy, particularly in patients with longer diabetes duration, those of male gender and advanced age, and those with uncontrolled blood pressure.Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- Comparison of Vascular Response to Statin Therapy in Patients With Versus Without Diabetes MellitusThe American Journal of Cardiology, 2019
- Treatment Gap in Primary Prevention Patients Presenting With Acute Coronary SyndromeThe American Journal of Cardiology, 2019
- Cardiovascular disease risk prediction in sub-Saharan African populations — Comparative analysis of risk algorithms in the RODAM studyInternational Journal of Cardiology, 2018
- Comparisons of the Framingham and Pooled Cohort Equation Risk Scores for Detecting Subclinical Vascular Disease in Blacks Versus WhitesThe American Journal of Cardiology, 2018
- Risk assessment in the prevention of cardiovascular disease in low-resource settingsIndian Heart Journal, 2016
- Statin Prescribing Patterns: An Analysis of Data From Patients With Diabetes in the National Hospital Ambulatory Medical Care Survey Outpatient Department and National Ambulatory Medical Care Survey Databases, 2005–2010Clinical Therapeutics, 2015
- The New Pooled Cohort Equations Risk CalculatorCanadian Journal of Cardiology, 2015
- Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic InflammationJACC, 2013
- Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: The Diabcare Africa studyDiabetes Research and Clinical Practice, 2012
- Diabetic dyslipidemia and atherosclerosis: Evidence from clinical trialsCurrent Diabetes Reports, 2008